Position in GH
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$338,467
+$121,398 QoQ
Shares Held
2,256
-4.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 31 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 49.68971631205674.ToString("F0")%
Shared 0.ToString("F0")%
None 50.310283687943254.ToString("F0")%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026EASTERN BANK holds $78,800,668 across 12 Diagnostics & Research names. GH ranks #5 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
189,969 | $40,263,929 | |
| 2 | DHR |
Danaher Corp /De/
|
175,279 | $33,387,143 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
5,699 | $2,857,250 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
5,646 | $1,091,258 | |
| 5 | GH |
Guardant Health, Inc.
This page
|
2,256 | $338,467 | |
| 6 | A |
Agilent Technologies, Inc.
|
2,496 | $331,543 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
506 | $266,377 | |
| 8 | WAT |
Waters Corp /De/
|
290 | $108,761 |
All Filings in GH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $338,467 | 2,256 | Shares | Defined | 2026-07-01 | |
| 2026-03-31 | $217,069 | 2,350 | Shares | Defined | 2026-04-07 | |
| 2025-12-31 | $220,622 | 2,160 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $126,272 | 2,021 | Shares | Defined | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||